Supplementary Figures from Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
Open Access
- 4 April 2023
- other
- Published by American Association for Cancer Research (AACR)